TanyaMTrippettMD

Clinical Trials

• Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma Start of enrollment: 1995 Aug 01

  Completed

  Phase 2

• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma Start of enrollment: 1996 Jan 01

  Completed

  Phase 2

• Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma Start of enrollment: 1999 Jan 01

  Completed

  Phase 2

• Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma Start of enrollment: 2001 May 01

  Completed

  Phase 2

• Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation Start of enrollment: 2004 May 01

  Terminated

  Phase 1

• Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Start of enrollment: 2004 Sep 01

  Completed

  Phase 1

• Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Start of enrollment: 2006 Jul 01

  Terminated

  Phase 2

• Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma Start of enrollment: 2007 Nov 13

  Completed

  Phase 2

• Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II) Start of enrollment: 1994 Mar 01

  Completed

  Phase 2

• Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH Start of enrollment: 1995 Jan 01

  Completed

  Phase 2

• A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) Start of enrollment: 1996 Mar 01

  Completed

  Phase 2

• LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma Start of enrollment: 1990 May 01

  Completed

  Phase 2

• Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors Start of enrollment: 2008 Oct 01

  Completed

  Phase 1

• External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30

  Completed

  Phase 2

• Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09

  Completed

  Phase 1, Phase 2

• Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• A Safety Study of SGN-CD19A for Leukemia and Lymphoma Start of enrollment: 2013 Feb 01

  Completed

  Phase 1

• Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment Start of enrollment: 2016 Oct 01

  Active, not recruiting

  Phase 1, Phase 2

• Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children Start of enrollment: 2016 Feb 16

  Completed

  Phase 1

  Roles: Contact, Principal Investigator

• Join now to see all